News

Press Release: PannTheraPi Receives ANSM Approval to Advance PTI5803 into Phase 2a in Focal Cortical Dysplasia

septembre 8, 2026

Press release: Panntherapi submitted the Phase2a trial for PTI5803 & appointed Sophie Binay as new General Manager and CSO

Press release: Panntherapi submitted the Phase2a trial for PTI5803 & appointed Sophie Binay as new General Manager and CSO

avril 14, 2026

Press Release: PannTheraPi prepares plans to conduct its first Phase IIa clinical trial

août 26, 2025

Validation of the PTI5803 Paediatric Investigation Plan

avril 12, 2025

Positive Phase 1 for PTI5803

février 6, 2025

Elsa Brillaud is part of the French Women Entrepreneurs 40

novembre 23, 2024

Presentation-Dr-simmons

Panntherapi is the first recipient of the Dr Simmons award

décembre 6, 2023

PannTheraPi is the winner of the Startup spotlight competition at the BioEurope

novembre 10, 2023

Panntherapi obtained the EIC Accelerator grant (2.5M€) and equity (9.8M€)

juin 20, 2023

TECHFORFUTURE_2022_SITE_POSTER_1920x1080

Panntherapi won the Tech for Future Health award

mai 15, 2023